Late Breaking Abstract - Safety and feasibility of a novel externally cooled bronchoscopic radiofrequency ablation catheter for ablation of peripheral lung tumours: a first-in-human dose escalation study
D. Steinfort (Melbourne, Australia), P. Antippa (Melbourne, Australia), K. Rangamuwa (Melbourne, Australia), L. Irving (Melbourne, Australia), M. Christie (Melbourne, Australia), E. Chan (Melbourne, Australia), D. Tanaka (Cupertino, United States), K. Yoneda (Sacramento, United States), J. Christie (Melbourne, Australia), F. Herth (Heidelberg, Germany), S. Raina (Santa Clara, United States)
Source: International Congress 2022 – Lung cancer: from screening to early diagnosis
Session: Lung cancer: from screening to early diagnosis
Session type: Oral Presentation
Number: 2269
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Steinfort (Melbourne, Australia), P. Antippa (Melbourne, Australia), K. Rangamuwa (Melbourne, Australia), L. Irving (Melbourne, Australia), M. Christie (Melbourne, Australia), E. Chan (Melbourne, Australia), D. Tanaka (Cupertino, United States), K. Yoneda (Sacramento, United States), J. Christie (Melbourne, Australia), F. Herth (Heidelberg, Germany), S. Raina (Santa Clara, United States). Late Breaking Abstract - Safety and feasibility of a novel externally cooled bronchoscopic radiofrequency ablation catheter for ablation of peripheral lung tumours: a first-in-human dose escalation study. 2269
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|